These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 26965286)

  • 1. A novel gene expression signature for bone metastasis in breast carcinomas.
    Savci-Heijink CD; Halfwerk H; Koster J; van de Vijver MJ
    Breast Cancer Res Treat; 2016 Apr; 156(2):249-59. PubMed ID: 26965286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific gene expression signature for visceral organ metastasis in breast cancer.
    Savci-Heijink CD; Halfwerk H; Koster J; Horlings HM; van de Vijver MJ
    BMC Cancer; 2019 Apr; 19(1):333. PubMed ID: 30961553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.
    Capulli M; Angelucci A; Driouch K; Garcia T; Clement-Lacroix P; Martella F; Ventura L; Bologna M; Flamini S; Moreschini O; Lidereau R; Ricevuto E; Muraca M; Teti A; Rucci N
    J Bone Miner Res; 2012 Nov; 27(11):2387-98. PubMed ID: 22714395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior.
    Savci-Heijink CD; Halfwerk H; Hooijer GKJ; Koster J; Horlings HM; Meijer SL; van de Vijver MJ
    Breast Cancer Res Treat; 2019 Apr; 174(3):649-659. PubMed ID: 30610490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study.
    Lawler K; Papouli E; Naceur-Lombardelli C; Mera A; Ougham K; Tutt A; Kimbung S; Hedenfalk I; Zhan J; Zhang H; Buus R; Dowsett M; Ng T; Pinder SE; Parker P; Holmberg L; Gillett CE; Grigoriadis A; Purushotham A
    Breast Cancer Res; 2017 Oct; 19(1):113. PubMed ID: 29029636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Breast Cancer to Bone (B2B) Metastases Research Program: a multi-disciplinary investigation of bone metastases from breast cancer.
    Brockton NT; Gill SJ; Laborge SL; Paterson AH; Cook LS; Vogel HJ; Shemanko CS; Hanley DA; Magliocco AM; Friedenreich CM
    BMC Cancer; 2015 Jul; 15():512. PubMed ID: 26156521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis-Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer.
    Kimbung S; Johansson I; Danielsson A; Veerla S; Egyhazi Brage S; Frostvik Stolt M; Skoog L; Carlsson L; Einbeigi Z; Lidbrink E; Linderholm B; Loman N; Malmström PO; Söderberg M; Walz TM; Fernö M; Hatschek T; Hedenfalk I;
    Clin Cancer Res; 2016 Jan; 22(1):146-57. PubMed ID: 26276891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of metastatic behaviour of breast cancer subtypes.
    Savci-Heijink CD; Halfwerk H; Hooijer GK; Horlings HM; Wesseling J; van de Vijver MJ
    Breast Cancer Res Treat; 2015 Apr; 150(3):547-57. PubMed ID: 25820592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status.
    Park YH; Lee S; Cho EY; Choi YL; Lee JE; Nam SJ; Yang JH; Ahn JS; Im YH
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):507-16. PubMed ID: 19956951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
    Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
    J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.
    Carter RZ; Micocci KC; Natoli A; Redvers RP; Paquet-Fifield S; Martin AC; Denoyer D; Ling X; Kim SH; Tomasin R; Selistre-de-Araújo H; Anderson RL; Pouliot N
    J Pathol; 2015 Apr; 235(5):760-72. PubMed ID: 25430721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of estrogen-responsive genes involved in breast cancer metastases to the bone.
    Wang J; Jarrett J; Huang CC; Satcher RL; Levenson AS
    Clin Exp Metastasis; 2007; 24(6):411-22. PubMed ID: 17593529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone metastasis in a novel breast cancer mouse model containing human breast and human bone.
    Xia TS; Wang GZ; Ding Q; Liu XA; Zhou WB; Zhang YF; Zha XM; Du Q; Ni XJ; Wang J; Miao SY; Wang S
    Breast Cancer Res Treat; 2012 Apr; 132(2):471-86. PubMed ID: 21638054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
    Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
    Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.
    Lehmann BD; Ding Y; Viox DJ; Jiang M; Zheng Y; Liao W; Chen X; Xiang W; Yi Y
    BMC Cancer; 2015 Mar; 15():179. PubMed ID: 25886164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microenvironmental stimuli affect Endothelin-1 signaling responsible for invasiveness and osteomimicry of bone metastasis from breast cancer.
    Bendinelli P; Maroni P; Matteucci E; Luzzati A; Perrucchini G; Desiderio MA
    Biochim Biophys Acta; 2014 Apr; 1843(4):815-26. PubMed ID: 24373848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
    Kuo WH; Chang YY; Lai LC; Tsai MH; Hsiao CK; Chang KJ; Chuang EY
    PLoS One; 2012; 7(9):e45831. PubMed ID: 23049873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A core invasiveness gene signature reflects epithelial-to-mesenchymal transition but not metastatic potential in breast cancer cell lines and tissue samples.
    Marsan M; Van den Eynden G; Limame R; Neven P; Hauspy J; Van Dam PA; Vergote I; Dirix LY; Vermeulen PB; Van Laere SJ
    PLoS One; 2014; 9(2):e89262. PubMed ID: 24586640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining biological gene expression signatures in predicting outcome in breast cancer: An alternative to supervised classification.
    Nuyten DS; Hastie T; Chi JT; Chang HY; van de Vijver MJ
    Eur J Cancer; 2008 Oct; 44(15):2319-29. PubMed ID: 18715778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genes and functions from breast cancer signatures.
    Huang S; Murphy L; Xu W
    BMC Cancer; 2018 Apr; 18(1):473. PubMed ID: 29699511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.